Organised by leading tech and PR company, Cofinitive –21towatch is back!
#21toWatch is a dedicated campaign to showcase and highlight the maybe lesser known, recognising those exciting new entries across all market sectors, and celebrating the very best work going on today in the region. With such diversity and ingenuity amongst the #21toWatch cohort, the attributes each submission is assessed on are Innovation, Challenge, Influence, Viability and Memorability.
The CPCA Growth Hub are proud to Sponsor the 21towatch awards.
The #21toWatch 2024 Shortlist for People:
Alicia Showering, CEO of BugBiome, is dedicated to developing natural and durable microbiome-based insect repellents.
Mark Golab, co-founder of Cambridge Surgical Models (CSM), a startup focusing on manufacturing a new generation of artificial anatomical models for surgical training.
Chantal Epp, founder and CEO of ClicknClear, a music rights-tech and licensing company solving complex music licensing issues faced across choreographed sports and performing arts.
Bakul Gupta, co-founder and CEO of Deliver Biosciences, developing nanoparticle-based vectors to control each cell inside the body to deliver affordable, scalable and potent cures.
Dr. Ahmed Waraky, a Postdoctoral Research Fellow at the Cambridge Stem Cell Institute and co-founder of K-Stem, is directing research that focuses on machine learning and single-cell omics to advance stem cell transplantation.
Christopher Mosedale,CEO of Matrix Bio, a company aiming to advance 3D cell culture through innovative applications of automation, artificial intelligence, and advanced manufacturing.
Douglas Brion, founder of Matta, a startup developing the universal operating system for 3D printers, leveraging the latest machine learning research and the power of the cloud to bring intelligence to additive manufacturing to radically change how humans make things.
Ismail Sami is a Research Fellow at University of Cambridge and Faraday Institution. He is the CEO and co-founder of award winning MoSTLi; creating the next generation energy storage solutions.
Jack Chengzhi Guo developed an award-winning technology that turns waste plastics into green hydrogen and other commodities with collaborators in Cambridge. He cofounded Protonera to bring the technology to scale.
Nadia Radzman is a plant biologist working on rehabilitating forgotten legumes back into the food system and is a co-founder of a startup that accelerates genetic improvements in challenging legume crops.
Paolo Bombelli and colleagues pioneered the development of a technology capable to generate electricity from the microbial photosynthesis. This novel technology can substitute portable batteries for powering billions of small electronic devices
Samantha Hodder developed an adaptive platform which uses stories and games to educate children (2-12 yrs) with cancer about their specific cancer’s biology and treatments.
Swetha Kannan is a Cambridge International Scholar pursuing her PhD at the Dept of Medicine. She is setting up her own healthcare start-up by spinning out two very novel, award-winning and globally recognised inventions in accessible cancer diagnostics/therapeutics.
The #21toWatch 2024 Shortlist for Companies:
BeyondMath is using AI to solve the complex simulation of physics in engineering design orders of magnitude faster, providing reductions in time, cost and environmental impact when taking designs to production.
Cambridge Vision Technology is a startup whose technology enables early detection of Alzheimer’s Disease using retinal scanning
Cellexcel has created a novel process to manufacture water-resistant bio-composite materials. These will replace conventional composites such as fiberglass & carbon fibre, as well as plastics and possibly metal.
clock.bio aims to extend and improve quality of life by reversing the harmful effects of time in our cells, harnessing the regenerative capabilities of human pluripotent stem cells.
Expression Edits proprietary platform developed at University of Cambridge improves transgene expression in mammalian systems. This has direct impact on recombinant protein yields and the quality and efficacy of DNA medicines.
Gigabiome leverage the advances in next-generation sequencing, microbiome science and AI to build technology for diagnosing antimicrobial resistance.
HotHouse Therapeutics harness plants to develop next-generation drugs by identifying pathways from source plants and creating synthetic ‘production crops’ for both existing and new molecules.
Kuano combines state-of-the-art simulation and AI to add quantum detail to structure-based drug discovery, helping to enable the design of next generation medicines.
Opto Biosystems is developing wireless, minimally-invasive, biological interfaces which communicate electrical information from the body, creating opportunities in advanced diagnostics and therapeutics, with primary focuses in oncology and neurology.
OutSee is a deep TechBio company exploiting our innovative computational approach to genomics for drug target discovery and precision medicine, extracting value from genomics datasets beyond the state-of-the-art.
Remedium Energy developing a new carbon capture technology, carbon capture battery, that captures CO2 from cement/steel plants and monetizes the variation in electricity price to make carbon capture profitable.
TraitSeq leverages cutting-edge AI to accurately predict complex agricultural traits, to develop high-yielding/climate-resilient crops, animal breeds, agrochemical/biological inputs, and gene edits to improve global food security and sustainable food production.
Vector Bioscience’s platform technology tailors nanomaterials for drug delivery applications. These nanomaterials are MOFs (Metal Organic Frameworks) can store 10x more molecules than other encapsulation methods and are designed and tailored for effective and targeted delivery.
Virilitas Labs is dedicated to improving and optimising services and interventions around male reproductive health and fertility by translating cutting edge research into applications for clinical and at home use.
The #21toWatch 2024 Shortlist for Innovations (Things):
EPIHERD (Antler Bio) – harnessing gene expression data and AI to evaluate the status of livestock and prescribe targeted husbandry interventions to increase performance, efficiency, welfare and sustainability.
Gus, the automated asparagus picker (Autopickr) – incorporates cutting-edge AI and navigation technologies, robust robotics, and new cutting technology to optimise the harvesting process.
Ediform – crafts exceptional food for those who can no longer find pleasure in eating but require tailored nutrition for their well-being.
Heartfelt Technologies – an automatic, AI supported, non-contact telemonitoring solution for heart failure patients.
Drawing Experiences (Human Experience Dynamics) – measuring subjective aspects of experiences, allowing users to graph their experiences in time, providing more sensitive, and precise measurement of mental health outcomes.
Lark Optics – created AR glasses that project images directly onto the user’s retina, eliminating the depth mismatch that causes discomfort and physical symptoms.
Lithium-sulfur (Li-S) battery future (Mostli) – developed a new cathode material to enable high energy-density to weight and long-life lithium-sulfur batteries, helping facilitate the net-zero transition.
OPAU – no-heat technology helps industry remove up to 98% water, transforming products into waterless, lightweight, preservative-free dry sheets without compromising quality and performance.
Supersense Technologies – remote monitoring product empowers families and carers with insights, alerts, and support to maximise the quality of life for their loved ones and enable respite for carers.
Tenyks – ‘AI doctor’ resolving issues for machine learning engineers working with computer vision data.
The Chemistry Shed – new biotechnology business that uses an innovative in silico platform, developed by scientists at the UEA, to accelerate the discovery of new medicines.
Verinnogen – building hand-held, innovative tools to directly profile physical properties of 3D surfaces with direct applications in pre-clinical oncology research.
William Oak Diagnostics – an innovative point-of-care test which simplifies the identification of various micronutrient deficiencies making maternal, child, and infant testing more accessible
Read more about 21towatch here.